Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$72.5 - $100.68 $259,622 - $360,535
-3,581 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $121,914 - $167,591
1,351 Added 60.58%
3,581 $342,000
Q1 2021

Apr 27, 2021

BUY
$116.57 - $155.01 $34,504 - $45,882
296 Added 15.31%
2,230 $294,000
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $234,382 - $334,408
-2,353 Reduced 54.89%
1,934 $256,000
Q4 2020

Jan 13, 2021

SELL
$99.61 - $142.12 $83,373 - $118,954
-837 Reduced 16.33%
4,287 $568,000
Q3 2020

Nov 02, 2020

BUY
$72.92 - $102.01 $55,637 - $77,833
763 Added 17.5%
5,124 $522,000
Q2 2020

Jul 21, 2020

BUY
$55.75 - $92.75 $243,125 - $404,482
4,361 New
4,361 $379,000
Q1 2020

Apr 14, 2020

SELL
$37.9 - $104.44 $82,394 - $227,052
-2,174 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$77.66 - $99.74 $168,832 - $216,834
2,174 New
2,174 $201,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.33B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.